Phase 1 Peripheral Arterial Disease Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
The Pharmacokinetics and Pharmacodynamics Study of CG-0255 Besylate and Plavix® in Healthy Participants
Peripheral Arterial DiseaseRecent Myocardial InfarctionRecent Stroke+1 more
Shanghai CureGene Pharmaceutical Co., Ltd.136 enrolled1 locationNCT07619885
Recruiting
Phase 1Phase 2
Effects of Carnosine In Patients With Peripheral Arterial Disease Patients
Peripheral Arterial Disease
Shahid Baba144 enrolled3 locationsNCT06480760
Recruiting
Phase 1Phase 2
Carnosine for Peripheral Arterial Disease Patients
Peripheral Arterial Disease
Shahid Baba20 enrolled1 locationNCT05371145